Antibiotics for Gram-Positive Bacterial Infections: Vancomycin, Teicoplanin, Quinupristin/Dalfopristin, Oxazolidinones, Daptomycin, Dalbavancin, and Telavancin
Authors:
- Jack D. SobelJSJack D. Sobel
- 1 December 2009
- journal article
- review article
- Published by Elsevier in Infectious Disease Clinics of North America
- Vol. 23 (4) , 965-982
Abstract
No abstract availableKeywords
This publication has 103 references indexed in Scilit:
- Characterization of Vancomycin-Heteroresistant Staphylococcus aureus from the Metropolitan Area of Detroit, Michigan, over a 22-Year Period (1986 to 2007)Journal of Clinical Microbiology, 2008
- Relationship between Vancomycin MIC and Failure among Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with VancomycinAntimicrobial Agents and Chemotherapy, 2008
- Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of NephrotoxicityAntimicrobial Agents and Chemotherapy, 2008
- Activity of Daptomycin Alone and in Combination with Rifampin and Gentamicin against Staphylococcus aureus Assessed by Time-Kill MethodologyAntimicrobial Agents and Chemotherapy, 2007
- Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused byStaphylococcus aureusNew England Journal of Medicine, 2006
- Induction of Daptomycin Heterogeneous Susceptibility in Staphylococcus aureus by Exposure to VancomycinAntimicrobial Agents and Chemotherapy, 2006
- Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997–2002)Diagnostic Microbiology and Infectious Disease, 2004
- In vitro Activity of Quinupristin/ Dalfopristin, RP59500, against Gram-Positive Clinical IsolatesChemotherapy, 1997
- Clinical Pharmacokinetics of VancomycinClinical Pharmacokinetics, 1986
- Clinical pharmacology and efficacy of vancomycin in pediatric patientsThe Journal of Pediatrics, 1980